The antigen specific composition of melanoma tumor infiltrating lymphocytes?

OncoImmunology

Volumn 1, Issue 6, 2012, Pages 935-936

  Hadrup, Sine Reker ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antigens; CD8 T cells; Melanoma; T cell epitopes; Tumor infiltrating lymphocytes

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CHEMICAL COMPOSITION; HUMAN; MELANOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR REGRESSION;

EID: 84886945112     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.20303     Document Type: Article

References (9)

1. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo N P, et al. Adoptive cell transfer therapy following non-myeloablative but lymphode-pleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23:2346-57; PMID:15800326; http://dx.doi.org/10.1200/JCO.2005.00.240.
2. Sick Andersen R, Thrue CA, Junker N, Lyngaa R, Donia M, Ellebaek E, et al. Dissection of T cell antigen specificity in human melanoma. Cancer Res 2012; In press; http://dx.doi.og/10.1158/0008-5472.CAN-11-2614.
3. Kvistborg P, Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients. OncoImmunology 2012; In press; PMID:22318430.
4. Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 2009; 6:520-6; PMID:19543285; http://dx.doi.org/10.1038/ nmeth.1345.
5. Toebes M, Coccoris M, Bins AD, Rodenko B, Gomez R, Nieuwkoop NJ, et al. Design and use of conditional MHC class I ligands. Nat Med 2006; 12:246-51; PMID:16462803; http://dx.doi.org/10.1038/nm1360.
6. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2011; 39:1171-6; PMID:21071412; http://dx.doi.org/10.1093/nar/gkq998.
7. Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immu-noediting. Nature 2012; 482:400-4; PMID:22318521; http://dx.doi.org/10.1038/nature10755.
8. Schreiber RD, Old LJ, Smyth MJ. Cancer immu-noediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/sci-ence.1203486.
9. Neudorfer J, Schmidt B, Huster KM, Anderl F, Schiemann M, Holzapfel G, et al. Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens. J Immunol Methods 2007; 320:119-31; PMID:17306825; http:// dx.doi.org/10.1016/j.jim.2007.01.001.